LMAT vs. UTHR

Last updated Jun 3, 2026

LMAT (LeMaitre Vascular, Inc.) and UTHR (United Therapeutics Corporation) are both stocks. Both are in the Healthcare sector — LMAT in Medical Instruments & Supplies, UTHR in Biotechnology. Over the past 10 years, LMAT returned 21.12%/yr vs 16.60%/yr for UTHR. At a 0.14 correlation, their price movements are largely independent.

Performance

LMAT vs. UTHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in LeMaitre Vascular, Inc. (LMAT) and United Therapeutics Corporation (UTHR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LMAT achieves a 13.51% return, which is significantly higher than UTHR's 10.84% return. Over the past 10 years, LMAT has outperformed UTHR with an annualized return of 21.12%, while UTHR has yielded a comparatively lower 16.60% annualized return.

LMAT

• 1D: 0.22%
• 1M: -18.02%
• YTD: 13.51%
• 6M: 10.01%
• 1Y: 15.00%
• 3Y*: 13.28%
• 5Y*: 13.37%
• 10Y*: 21.12%

UTHR

• 1D: -0.84%
• 1M: -5.32%
• YTD: 10.84%
• 6M: 13.90%
• 1Y: 65.92%
• 3Y*: 35.47%
• 5Y*: 25.24%
• 10Y*: 16.60%

*Multi-year figures are annualized to reflect compound growth (CAGR)

LMAT vs. UTHR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LMAT LeMaitre Vascular, Inc.	13.51%	-10.95%	63.63%	24.60%	-7.40%	25.10%	14.09%	53.77%	-25.13%	26.58%
UTHR United Therapeutics Corporation	10.84%	38.09%	60.46%	-20.93%	28.70%	42.35%	72.33%	-19.12%	-26.39%	3.15%

Correlation

The correlation between LMAT and UTHR is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.08
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (5Y) Calculated over the trailing 5-year period	0.18
Correlation (10Y) Calculated over the trailing 10-year period	0.19
Correlation (All Time) Calculated using the full available price history since Oct 20, 2006	0.14

The correlation between LMAT and UTHR shifts across timeframes, from 0.08 (1 year) to 0.19 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap LMAT : $2.11B UTHR : $25.49B
EPS LMAT : $2.68 UTHR : $27.00
PE Ratio LMAT : 34.24 UTHR : 20.00
PEG Ratio LMAT : 1.47 UTHR : 0.66
PS Ratio LMAT : 8.34 UTHR : 8.12
PB Ratio LMAT : 5.19 UTHR : 4.32
Total Revenue (TTM) LMAT : $256.28M UTHR : $3.17B
Gross Profit (TTM) LMAT : $185.52M UTHR : $2.74B
EBITDA (TTM) LMAT : $90.48M UTHR : $1.75B

Return for Risk

LMAT vs. UTHR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LMAT

LMAT Risk / Return Rank: 53
LMAT Sharpe Ratio Rank: 55
LMAT Sortino Ratio Rank: 54
LMAT Omega Ratio Rank: 52
LMAT Calmar Ratio Rank: 53
LMAT Martin Ratio Rank: 53

UTHR

UTHR Risk / Return Rank: 85
UTHR Sharpe Ratio Rank: 78
UTHR Sortino Ratio Rank: 85
UTHR Omega Ratio Rank: 85
UTHR Calmar Ratio Rank: 88
UTHR Martin Ratio Rank: 88

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LMAT vs. UTHR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for LeMaitre Vascular, Inc. (LMAT) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LMAT	UTHR	Difference
Sharpe ratio Return per unit of total volatility	0.41	1.33	-0.92
Sortino ratio Return per unit of downside risk	1.04	2.72	-1.68
Omega ratio Gain probability vs. loss probability	1.12	1.37	-0.25
Calmar ratio Return relative to maximum drawdown	0.57	4.24	-3.67
Martin ratio Return relative to average drawdown	1.18	11.00	-9.81
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LMAT vs. UTHR - Sharpe Ratio Comparison

The current LMAT Sharpe Ratio is 0.41, which is lower than the UTHR Sharpe Ratio of 1.33. The chart below compares the historical Sharpe Ratios of LMAT and UTHR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LMAT	UTHR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.41	1.33	-0.92
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.37	0.72	-0.35
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.51	0.47	+0.04
Sharpe Ratio (All Time) Calculated using the full available price history	0.34	0.38	-0.05

Drawdowns

LMAT vs. UTHR - Drawdown Comparison

The maximum LMAT drawdown since its inception was -75.69%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for LMAT and UTHR.

Drawdown Indicators

	LMAT	UTHR	Difference
Max Drawdown Largest peak-to-trough decline	-75.69%	-93.18%	+17.49%
Max Drawdown (1Y) Largest decline over 1 year	-21.93%	-16.35%	-5.58%
Max Drawdown (3Y) Largest decline over 3 years	-33.32%	-33.00%	-0.32%
Max Drawdown (5Y) Largest decline over 5 years	-37.93%	-33.00%	-4.93%
Max Drawdown (10Y) Largest decline over 10 years	-47.65%	-55.56%	+7.91%
Current Drawdown Current decline from peak	-21.76%	-9.50%	-12.26%
Average Drawdown Average peak-to-trough decline	-18.95%	-35.33%	+16.38%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.56%	6.31%	+4.25%

Volatility

LMAT vs. UTHR - Volatility Comparison

LeMaitre Vascular, Inc. (LMAT) has a higher volatility of 10.00% compared to United Therapeutics Corporation (UTHR) at 8.37%. This indicates that LMAT's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LMAT	UTHR	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.00%	8.37%	+1.63%
Volatility (6M) Calculated over the trailing 6-month period	29.18%	26.04%	+3.14%
Volatility (1Y) Calculated over the trailing 1-year period	36.61%	49.79%	-13.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	36.40%	35.16%	+1.24%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	41.47%	35.10%	+6.37%

Dividends

LMAT vs. UTHR - Dividend Comparison

LMAT's dividend yield for the trailing twelve months is around 0.98%, while UTHR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
LMAT LeMaitre Vascular, Inc.	0.98%	1.23%	0.69%	0.99%	1.09%	0.88%	0.94%	0.95%	1.18%	0.69%	0.71%	0.93%
UTHR United Therapeutics Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

LMAT vs. UTHR - Profitability Comparison

The chart below illustrates the profitability comparison between LeMaitre Vascular, Inc. and United Therapeutics Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

LMAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, LeMaitre Vascular, Inc. reported a gross profit of 48.40M and revenue of 66.55M. Therefore, the gross margin over that period was 72.7%.

UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.

LMAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, LeMaitre Vascular, Inc. reported an operating income of 17.78M and revenue of 66.55M, resulting in an operating margin of 26.7%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.

LMAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, LeMaitre Vascular, Inc. reported a net income of 15.68M and revenue of 66.55M, resulting in a net margin of 23.6%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.

Frequently Asked Questions

Can I hold both LMAT and UTHR in my portfolio?

LMAT and UTHR have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LMAT or UTHR?

LMAT has higher volatility (10.00%) compared to UTHR (8.37%). In terms of maximum drawdown, LMAT dropped -75.69% vs UTHR's -93.18%.

Which has better risk-adjusted returns?

UTHR currently has the higher Sharpe Ratio (1.33 vs 0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.